loading
前日終値:
$4.94
開ける:
$4.9
24時間の取引高:
135.52K
Relative Volume:
0.55
時価総額:
$55.83M
収益:
$52.29M
当期純損益:
$-73.52M
株価収益率:
-7.6288
EPS:
-0.66
ネットキャッシュフロー:
$-100.45M
1週間 パフォーマンス:
+7.76%
1か月 パフォーマンス:
+9.41%
6か月 パフォーマンス:
-1.57%
1年 パフォーマンス:
-49.75%
1日の値動き範囲:
Value
$4.85
$5.10
1週間の範囲:
Value
$4.4601
$5.2499
52週間の値動き範囲:
Value
$3.61
$11.09

Precision Biosciences Inc Stock (DTIL) Company Profile

Name
名前
Precision Biosciences Inc
Name
セクター
Healthcare (1167)
Name
電話
919-314-5512
Name
住所
302 EAST PETTIGREW STREET, DURHAM, NC
Name
職員
107
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
DTIL's Discussions on Twitter

DTIL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DTIL
Precision Biosciences Inc
5.035 53.89M 52.29M -73.52M -100.45M -0.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.03 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
570.65 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.49 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
590.82 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.29 31.99B 3.81B -644.79M -669.77M -6.24

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 アップグレード BMO Capital Markets Market Perform → Outperform
2024-04-30 開始されました Guggenheim Buy
2022-06-17 開始されました BMO Capital Markets Outperform
2022-06-09 ダウングレード William Blair Outperform → Mkt Perform
2020-07-27 再開されました BTIG Research Buy
2020-04-03 ダウングレード Goldman Buy → Neutral
2020-03-05 開始されました Stifel Buy
2020-02-25 開始されました William Blair Outperform
2019-08-09 開始されました BTIG Research Buy
2019-07-16 開始されました H.C. Wainwright Buy
2019-04-22 開始されました Barclays Overweight
2019-04-22 開始されました Goldman Buy
2019-04-22 開始されました JP Morgan Overweight
2019-04-22 開始されました Jefferies Buy
すべてを表示

Precision Biosciences Inc (DTIL) 最新ニュース

pulisher
Jul 23, 2025

Precision BioSciences shares climb after FDA grants orphan drug status - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD - Contract Pharma

Jul 23, 2025
pulisher
Jul 23, 2025

Precision Biosciences’ PBGENE-DMD gains US orphan drug designation - BioWorld MedTech

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Precision BioSciences Inc. stockFree Trading Strategy Suggestions - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Precision BioSciences stock rises after FDA grants orphan drug status By Investing.com - Investing.com Canada

Jul 23, 2025
pulisher
Jul 23, 2025

FDA grants orphan drug status to Precision BioSciences’ DMD treatment - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

FDA grants orphan drug status to Precision BioSciences’ DMD treatment By Investing.com - Investing.com Nigeria

Jul 23, 2025
pulisher
Jul 23, 2025

Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Business Wire

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Precision BioSciences Inc. stock priceFastest return on investment - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Precision BioSciences Inc. Stock Analysis and ForecastFree Capital Growth Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Precision BioSciences Secures Orphan Drug Designation for DMD Treatment, DTIL Stock News - AInvest

Jul 19, 2025
pulisher
Jul 17, 2025

Precision BioSciences Duchenne muscular dystrophy treatment gets orphan status - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Precision BioSciences gets FDA orphan drug designations for DMD treatment By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 16, 2025

Precision BioSciences reports promising DMD gene editing results By Investing.com - Investing.com Canada

Jul 16, 2025
pulisher
Jul 16, 2025

Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic - Business Wire

Jul 16, 2025
pulisher
Jul 16, 2025

How Precision BioSciences Inc. stock performs during market volatilityFree Market Sentiment Analysis - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Why Precision BioSciences Inc. stock attracts strong analyst attentionPortfolio Boosting Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Precision BioSciences Inc. stock price move sharplyTriple Digit Return Forecasts - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

(DTIL) Proactive Strategies - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 08, 2025

Precision Biosciences CFO Sells Shares to Cover Tax Obligations - TradingView

Jul 08, 2025
pulisher
Jun 30, 2025

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 3000E Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 27, 2025

Insider Buying: Kevin Buehler Acquires Shares of Precision BioSciences Inc (DTIL) - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Precision Biosciences director Brown buys $6963 in DTIL stock - Investing.com

Jun 27, 2025
pulisher
Jun 25, 2025

Precision BioSciences stock jumps after FDA grants rare pediatric designation By Investing.com - Investing.com UK

Jun 25, 2025
pulisher
Jun 18, 2025

A startup banks $66M to pursue ‘inclusive precision medicine’ - BioPharma Dive

Jun 18, 2025
pulisher
Jun 03, 2025

precision biosciences reports voting outcomes at annual shareholder meeting By Investing.com - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

precision biosciences reports voting outcomes at annual shareholder meeting - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Precision BioSciences Holds Annual Stockholder Meeting - TipRanks

Jun 03, 2025
pulisher
May 21, 2025

Precision BioSciences (DTIL): Rating Reaffirmed at Buy with $60 Target | DTIL Stock News - GuruFocus

May 21, 2025
pulisher
May 16, 2025

Precision BioSciences: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

Precision BioSciences Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Transcript : Precision BioSciences, Inc.Special Call - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Precision BioSciences Inc Reports Q1 2025 EPS of $(2.21) and Rev - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Precision BioSciences Reports Q1 Results and Business Update - TipRanks

May 15, 2025

Precision Biosciences Inc (DTIL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.62
price up icon 3.30%
$36.54
price up icon 1.50%
$103.51
price up icon 0.10%
$27.56
price down icon 1.79%
$114.12
price down icon 0.42%
biotechnology ONC
$295.14
price up icon 0.11%
大文字化:     |  ボリューム (24 時間):